Preliminary program

Day 1 - Friday, 6 March 2020

 08:30 AMOpening of the Workshop 

Pozniak, Anton 2019 2
Opening Lecture
Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College, UK

 Session 1:  Research in HIV and Women Over the Last Decade:  Successes and Challenges 
 08:55 AM

Sharon Walmsley, FRCPC, MD, MSc

Antiretroviral Therapy, Women in Clinical Trials 
Sharon Walmsley, MD - Toronto University, Canada

 09:10 AM

Lynne Mofenson, MD

Prevention of Mother-to-Child Transmission
Lynne Mofenson, MD - Elizabeth Glaser AIDS Foundation, USA

 09:25 AM

Van der Straten, Ariane 2019 120x160

Prevention Options for Women
Ariane van der Straten, PhD - RTI International / UCSF, USA

 09:40 AM

Currier, Judith 2020 120x160

Comorbidities of Importance to Women
Judith Currier, MD - UCLA, USA

 09:55 AM

Sherr, Lorraine 2020 120x160

Psychosocial issues for women living with HIV
Lorraine Sherr, BA, DipClinPsych, PhD - University College London, UK

 10:10 AM

Clayden, Polly 2020 120x160

Involvement of Women Living with HIV in Research
Polly Clayden - iBase, UK

 10:25 AMCoffee Break 
  Abstract-Driven Presentations 
 10:55 AM

Sex-specific analyses in oral abstracts from CROI 2019
William Short, MD, MPH - University of Pennsylvania, USA

 11:10 AM

Outcomes following prenatal exposure to Dolutegravir: the Dolomite - EPPICC Study
Claire Thorne, BA, MSc, PhD - University College London, UK 

 11:25 AM

Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort study
Ellen Moseholm, MScH, PhD - Copenhagen University Hospital, Hvidovre, Denmark

 11:40 AM

Impact of Dolutegravir based  ART among Indian women
Poongulali Selvamuthu, MD - CART CRS /Infectious Diseases Medical Center, India


 11:55 AMDiscussion 
 12:25 PMGroup Picture 
 12:40 PM

Meet-the-expert Lunch
Table 1:  Antiretroviral trials:  Annette Haberl, Sharon Walmsley
Table 2:  PrEP:  Catherine Hankins, Sally Hodder
Table 3:  Pregnancy and breastfeeding:  Lynn Mofenson, Deborah Money, Natella Rakhmanina
Table 4:  Aging women:  Giovanni Guaraldi, Margaret Johnson
Table 5:  Mental health:  Mona Loutfy, Lorraine Sherr

 Session 2:  Debate:  U=U does not apply to women
 01:40 PM 

A Pro-Con Debate Involving Experts and Community Representatives


Natella Rakhmanina, MD, PhD, FAAP, AAHIVS

Natella Rakhmanina, MD, PhD - The George Washington University, Children’s National Health System, USA


Lena Serghides, PhD

 Lena Serghides, PhD - University Health Network, Canada


Fungai Murau

Fungai Murau, MA - IDS, UK


Sutherland, Lisa 2020 120x160

Lisa Sutherland - Social Worker, Canada

 02:40 PM

Coffee Break

  Abstract-Driven Presentations 
 03:10 PM

Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV - negative pregnant women
Lena Serghides, PhD - University Health Network, Canada

 03:25 PM

Adolescent girls and young women: Should they be formally recognized as a key population for HIV?
Madlen Nash, MSc - AIDS-Free World, Canada

 03:40 PM

Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA  <50 copies/ml compared to men –  Real World Data from the National Swedish InfCareHIV 
Asa Mellgren, MD, PhD - Clinic Of Infectious Diseases, Sweden 

 03:55 PM

Not recommended, but done: Breastfeeding with HIV in Germany 
Lila Haberl, MD - Hivcenter, University Hospital, Goethe University, Germany

 04:10 PMDiscussion 
 Session 3: ART Research in Pregnant and Breastfeeding Women
 04:25 PM

Lockman, Shahin 2020 120x160

Better, earlier pregnancy and lactation data for new HIV drugs: how do we get there
Shahin Lockman, MD, MSc - Harvard T.H. Chan School of Public Health, USA 

 04:40 PMRound Table Discussion 

Penazzato, Martina 2018

Martina Penazzato, MD, DTMH, MSC, PhD - World Health Organization, Switzerland


Lockman, Shahin 2020 120x160

Shahin Lockman, MD, MSc - Harvard T.H. Chan School of Public Health, USA 


Philadelphia Literacy

Kathleen Squires, MD - Merck Research Labs, USA

 5:10 PMWelcome drinks, poster viewing session and guided poster tour 1 

Women Race, Age and Regional US & Non-US Subgroup Analysis of Dolutegravir (DTG) and Non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48
Romina Quercia


ATLAS and FLAIR: Efficacy, pharmacokinetics and reasons for satisfaction in women with Cabotegravir & Rilpivirine long-acting regimen at week 48 
Romina Quercia


Dolutegravir-containing ART does not reduce etonogestrel implant concentrations
Rena Patel


Cabotegravir: Assessment of reproductive and developmental toxicity in animal studies 1
M.K. Ziejewski 



Cabotegravir pharmacokinetic tail in pregnancy and neonatal outcomes 
Parul Patel


Day 2 - Saturday, 7 March 2020

 Session 4: 90:90:90: Which Women Are Being Left Behind?
 08:30 AM

Hodder, Sally 2018

North America 
Sally Hodder, MD - West Virginia University, USA

 08:45 AM

Mariana Mardarescu, MD, PhD

Eastern Europe
Mariana Mardarescu, MD, PhD - Institute for Infectious Disease M. Bals, Romania

 09:00 AM

Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana

 09:15 AM

Patricia Vasquez, MD

South America
Patricia Vasquez, MD - Hospital San Juan de Dios, Chile

 09:30 AM

Vidya Mave, MD - Bj Government Medical College, India

 09:45 AMDiscussion 
 10:15 AMCoffee Break, poster viewing session
  Guided poster tour 2: Pregnancy 

Achieving the third 95: Keeping adolescents living with HIV virally suppressed in rural Nigeria in test and treat era using Continuous Quality Improvement Model of Peer Counseling & Support Group
Saheed Usman


Timing of HIV diagnosis in HIV-positive pregnant women giving birth in a high prevalence Russian region
Rebecca Sconza

  Mode of birth among women living with HIV: A population-based retrospective cohort study
Esther Shoemaker
  Prevalence of polypharmacy and medication use contraindicated during pregnancy among a cohort of women living with HIV who are of childbearing age, 2016-2017
William Short
  Clinical trial simulation to improve HIV pre-exposure prophylaxis dosing in pregnancy
Rachel Scott
  Guided poster tour 2: HIV transmission and progression  

Social media influence on the sexual behaviours of undergraduate students of the university of Buea, Cameroon
Ikome Theckla Efeti


Why does sex make a difference in HIV clinical course? A bioinformatics analysis of differential expressed gene in male and female with HIV disease
Kulachanya Suwanwongse

  HIV transmission patterns among people who inject drugs in the United States
Samira Sami
  Disparities in PrEP uptake and adherence: implementation of routine adherence monitoring in Philadelphia PrEP clinic
Elijah Kahn-Woods
  HIV/AIDS Prevention Interventions for Black Women in the U.S.:
A Systematic Review
Amber Sophus
 Session 5:  Abstract-Driven Presentations
 11:15 AM 

Determinants of PrEP initiation in women at high risk for HIV
Rachel Scott, MD, MPH - Medstar Washington Hospital Center, USA

 11:30 AM

Validating incident pregnancies among women using contraceptives and antiretrovirals
Rena Patel, MD - University of Washington, USA

 11:45 AM

Post-Exposure Prophylaxis in Victims of Sexual Violence: Experience at the Condesa Specialized Clinic (CSC)
Teresita Cabrera, MD - Clínica Especializada Condesa, Mexico 

 12:00 PM

Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men 
Kalysha Closson, MSc - University of British Columbia, Canada

 12:15 PMDiscussion 
 12:30 PMLunch 
 Session 6: Women Surviving and Aging with HIV
 01:30 PM

Gustafson, Deborah 2019 120x160

WIHS Cohort
Deborah Gustafson, MS, PhD - SUNY Downstate Health Sciences University, USA

 02:00 PM

Giovanni Guaraldi 2017 120x160

Modena Cohort
Giovanni Guaraldi, MD - University of Modena and Reggio Emilia, Italy

 02:30 PMAveritt, Dawn 2020 120x160
Community Perspective
Dawn Averitt - The Well Project/WRI, USA
  Abstract-Driven Presentations 
 02:45 PM 

CD4:CD8 ratio normalization among treatment naive women
Alice Zhabokritsky, MD - University Of Toronto, Canada

 03:00 PM

Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV
Chinyere Okoli, PharmD - ViiV Healthcare, UK  


Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries
Chinyere Okoli, PharmD - ViiV Healthcare, UK 


Gender, equality, and empowered decision-making in HIV care
Chinyere Okoli, PharmD - ViiV Healthcare, UK 

 03:15 PM

Impact of Microbial Exposures on HPV Immune Titers and Infection Among HPV-Vaccinated Women Living with HIV
Elisabeth McClymont, MD - University of British Columbia, Canada


 03:30 PMDiscussion 
 03:45 PMClosing of the Workshop